Cytotoxic effects of pemetrexed in gastric cancer cells.
about
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions.Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.
P2860
Cytotoxic effects of pemetrexed in gastric cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cytotoxic effects of pemetrexed in gastric cancer cells.
@en
Cytotoxic effects of pemetrexed in gastric cancer cells.
@nl
type
label
Cytotoxic effects of pemetrexed in gastric cancer cells.
@en
Cytotoxic effects of pemetrexed in gastric cancer cells.
@nl
prefLabel
Cytotoxic effects of pemetrexed in gastric cancer cells.
@en
Cytotoxic effects of pemetrexed in gastric cancer cells.
@nl
P2093
P2860
P1433
P1476
Cytotoxic effects of pemetrexed in gastric cancer cells.
@en
P2093
Hye Seon Ham
Hyun-Soon Jong
Jee Hyun Kim
Keun-Wook Lee
Kyung Hae Jung
Noe Kyeong Kim
Seock-Ah Im
Tae-You Kim
Tai Young Kim
Yeonjoo Jung
P2860
P304
P356
10.1111/J.1349-7006.2005.00058.X
P577
2005-06-01T00:00:00Z